It looks like a private company with strong links to India and offices in the US and Mexico. A team of 7 management and 10 advisory doctors. That doesn't diminish it as a competitor but raises questions about funding requirements. I see there is no government backing for the trials they are doing on CV-19.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-2225
-
- There are more pages in this discussion • 15,624 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
-0.025(2.45%) |
Mkt cap ! $1.153B |
Open | High | Low | Value | Volume |
$1.02 | $1.04 | 99.5¢ | $3.836M | 3.782M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.0¢ | 6000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 1.060 |
1 | 723 | 1.035 |
3 | 362 | 1.025 |
4 | 5066 | 1.020 |
1 | 30636 | 1.005 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 15660 | 4 |
0.950 | 30112 | 3 |
0.955 | 8561 | 2 |
0.970 | 26489 | 5 |
0.985 | 13947 | 2 |
Last trade - 15.59pm 01/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |